NCT05465265View on ClinicalTrials.gov

PrEP for Prevention of HIV Transmission Among People Who Inject Drugs in Nairobi, Kenya

NACompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

July 30, 2022

Study Completion Date

July 30, 2022

Conditions
HIV Antibody PositivityPrEP Uptake
Interventions
BEHAVIORAL

Navigation into prEP by use of PrEP-UP intervention (provision of PrEP information through 5 counselling sessions, peer support, booking of appointments for PWIDs)

Cases: Navigation of PWID into PrEP-Navigation into prEP by use of PrEP-UP intervention (provision of PrEP information through 5 counselling sessions, peer support, booking of appointments for PWIDs) Control group: Provision of PrEP information to PWID through pamphlets on PrEP uptake, adherence and retention among PWID.

Trial Locations (1)

254

Pangani DIC, Ngara DIC, Githurai DIC, Kawangware DIC, Nairobi

All Listed Sponsors
collaborator

Kenyatta National Hospital

OTHER_GOV

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

University of Washington

OTHER

NCT05465265 - PrEP for Prevention of HIV Transmission Among People Who Inject Drugs in Nairobi, Kenya | Biotech Hunter | Biotech Hunter